Ariad


Stock Update (NASDAQ:ARIA): Ariad Pharmaceuticals, Inc. Announces Launch of Inaugural ALK+ Day During Lung Cancer Awareness Month

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the launch of an inaugural awareness day for anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer …

H.C. Wainwright Boosts Price Target For Ariad Pharmaceuticals On The Back Of 4Q14 Iclusig Sales

In a research report released on Monday, H.C.

We Continue To Think Ariad Is Fairly Valued, Says Cowen; Sees 28% Downside

In a research report sent to investors, Cowen analyst Phil Nadeau maintained a Market Perform rating on Ariad Pharmaceuticals (NASDAQ:ARIA) with a $4.50 …

Ariad Pharmaceuticals: Optimized Iclusig Dosing Could Be Key To Sales, Says H.C. Wainwright

In a research report issued this morning, H.C.

Shares Of Ariad Are Undervalued And Present Upside, Says H.C. Wainwright

In a research report published today, H.C.

H.C. Wainwright Keeps ‘Buy’ On Ariad Following $200 Million Offering

In a research note issued today, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts